Range Cancer Therapeutics ETF (CNCR)
14.96
+0.22
(+1.49%)
USD |
NASDAQ |
Nov 04, 16:00
CNCR Monthly Value at Risk (VaR) 5% (Since Inception)
Monthly Value at Risk (VaR) 5% (Since Inception) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Monthly Value at Risk (VaR) 5% (Since Inception) Data
| Date | Value |
|---|---|
| September 30, 2024 | -- |
| August 31, 2024 | -- |
| July 31, 2024 | -- |
| June 30, 2024 | -- |
| May 31, 2024 | -- |
| April 30, 2024 | -- |
| March 31, 2024 | -- |
| February 29, 2024 | -- |
| January 31, 2024 | -- |
| December 31, 2023 | -- |
| November 30, 2023 | -- |
| October 31, 2023 | -- |
| September 30, 2023 | -- |
| August 31, 2023 | -- |
| July 31, 2023 | -- |
| June 30, 2023 | -- |
| May 31, 2023 | -- |
| April 30, 2023 | -- |
| March 31, 2023 | -- |
| February 28, 2023 | -- |
| January 31, 2023 | -- |
| December 31, 2022 | -- |
| November 30, 2022 | -- |
| October 31, 2022 | -- |
| September 30, 2022 | -- |
| Date | Value |
|---|---|
| August 31, 2022 | -- |
| July 31, 2022 | -- |
| June 30, 2022 | -- |
| May 31, 2022 | -- |
| April 30, 2022 | -- |
| March 31, 2022 | -- |
| February 28, 2022 | -- |
| January 31, 2022 | -- |
| December 31, 2021 | -- |
| November 30, 2021 | -- |
| October 31, 2021 | -- |
| September 30, 2021 | -- |
| August 31, 2021 | -- |
| July 31, 2021 | -- |
| June 30, 2021 | -- |
| May 31, 2021 | -- |
| April 30, 2021 | -- |
| March 31, 2021 | -- |
| February 28, 2021 | -- |
| January 31, 2021 | -- |
| December 31, 2020 | -- |
| November 30, 2020 | -- |
| October 31, 2020 | -- |
| September 30, 2020 | -- |
| August 31, 2020 | -- |